Table 1. Detailed characteristics of eligible studies considered in the meta-analysis.
| First author | Year | Ethnicity | Region | Single-nucleotide polymorphism | Diagnostic criteria | Matching | Source | Method |
| Ge [16] | 2000 | Tibetan | Tibet | A-6G | SBP≥140, DBP≥90 | Yes | P-B | PCR-RFLP |
| Hu [14] | 2007 | Mongolian | Inner Mongolian | A-6G | SBP≥140, DBP≥90 | Yes | P-B | Sequencing technique |
| Jiang [17] | 2009 | Han | Jiangsu | A-6G, A-20C | SBP≥140, DBP≥90 | Yes | P-B | TaqMan - PCR |
| Kong [15] | 2002 | Han | Henan | A-6G, A-20C | SBP≥160, DBP≥95 | Yes | H-B | PCR-RFLP |
| Liu [38] | 2002 | Han | Shanghai | A-6G | SBP≥140, DBP≥90 | No | H-B | Sequencing technique |
| Li [22] | 2004 | Kazakh | Xinjiang | A-20C | SBP≥140, DBP≥90 | Yes1 | P-B | PCR-SSCP |
| Liu [12] | 2001 | Tibetan | Tibet | A-6G | SBP>140, DBP>90 | Yes | P-B | PCR-RFLP |
| Liu [12] | 2001 | Yi | Sichuan | A-6G | SBP>140, DBP>90 | Yes | P-B | PCR-RFLP |
| Qi [7] | 2008 | Han | Beijing | A-6G, A-20C | SBP≥140, DBP≥90 | Yes1 | P-B | PCR-RFLP |
| Wang [9] | 2002 | Amis | Taiwan | A-6G | SBP≥140, DBP≥90 | Yes | H-B | Sequencing technique |
| Wang [18] | 2003 | Kazakh | Xinjiang | A-6G | SBP≥160, DBP≥95 | Yes | P-B | MS-PCR |
| Wang [11] | 2007 | Li | Hainan | A-6G, A-20C | SBP≥140, DBP≥90 | Yes | H-B | Sequencing technique |
| Wu [10] | 2004 | Han | Taiwan | A-6G | SBP≥140, DBP≥90 | Yes1 | H-B | Sequencing technique |
| Yang [23] | 2000 | Tibetan | Tibet | A-20C | SBP≥140, DBP≥90 | Yes | P-B | PCR-RFLP |
| Yao [19] | 2010 | Bai | Yunnan | A-6G | SBP≥140, DBP≥90 | No | H-B | PCR-RFLP |
| Ying [20] | 2010 | Mongolian | Inner Mongolian | A-6G, A-20C | SBP≥140, DBP≥90 | No | P-B | PCR-RFLP |
| Yue [21] | 2008 | Han | Hebei | A-6G, A-20C | SBP≥140, DBP≥90 | Yes2 | P-B | PCR-RFLP |
| Liu [24] | 2004 | Han | Shanghai | A-20C | SBP>140, DBP>90 | No | H-B | Sequencing technique |
Abbreviations: SBP, systolic blood pressure (mmHg); DBP, diastolic blood pressure (mmHg); P-B, population-based study; H-B, hospital-based study; PCR-RFLP, polymerase chain reaction and restriction fragment length polymorphism; PCR-SSCP, polymerase chain reaction and single strand conformation polymorphism; MS-PCR, mutagenically separated polymerase chain reaction; Yes, age- and gender- matched, Yes1, gender-matched, Yes2, age-matched.